List of insiders holdings for AN2 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Leonard Braden Michael 10% Owner |
2024-08-14 20:24:00 | 0 5,749,432 |
5,749,432 | Form 4 |
| 2 | Aziz Kabeer Director |
2025-04-11 17:03:16 | 18,677 2,373,500 |
2,392,177 | Form 4 |
| 3 | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
2025-02-28 19:57:57 | 2,373,500 0 |
2,373,500 | Form 13G |
| 4 | Easom Eric Chief Executive Officer |
2025-02-28 16:22:36 | 536,880 1,259,882 |
1,796,762 | Form 4 |
| 5 | Readnour Robin Shane Director |
2024-12-23 18:32:55 | 9,077 1,234,861 |
1,243,938 | Form 4 |
| 6 | Zakrzewski Joseph S Director |
2025-04-11 17:08:46 | 145,538 405,880 |
551,418 | Form 4 |
| 7 | Eizen Joshua M See Remarks |
2025-02-28 16:22:55 | 292,172 0 |
292,172 | Form 4 |
| 8 | Chanda Sanjay Chief Development Officer |
2025-02-28 16:27:15 | 180,574 0 |
180,574 | Form 4 |
| 9 | Day Lucy Chief Financial Officer |
2025-02-28 16:26:12 | 172,170 0 |
172,170 | Form 4 |
| 10 | Prior Stephen David Chief Strategy Officer |
2025-02-28 16:19:36 | 117,313 0 |
117,313 | Form 4 |
| 11 | Spigelman Melvin K Director |
2024-06-21 17:58:43 | 64,503 0 |
64,503 | Form 4 |
| 12 | FitzPatrick Margaret M Director |
2024-06-21 18:18:17 | 64,503 0 |
64,503 | Form 4 |
| 13 | Wong Stephanie Director |
2024-06-21 17:50:49 | 64,503 0 |
64,503 | Form 4 |
| 14 | Eckburg Paul Chief Medical Officer |
2024-03-29 16:19:03 | 51,416 0 |
51,416 | Form 4/A |
| 15 | Marks Gilbert Lynn Director |
2025-04-11 16:55:55 | 41,507 0 |
41,507 | Form 4 |
| 16 | Krause Kevin Michael Chief Strategy Officer |
2024-03-29 16:17:22 | 31,914 0 |
31,914 | Form 4/A |
| 17 | Nazak Michael Adrian Chief Accounting Officer |
2023-02-17 19:23:22 | 16,600 0 |
16,600 | Form 4 |
| 18 | Martin Patricia A. Director |
2025-04-11 16:57:47 | 6,231 0 |
6,231 | Form 4 |
| 19 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
2025-02-14 18:27:01 | 0 0 |
0 | Form 13G |